4 hasil untuk "Andrea Rubbert-Roth"

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

Rieke Alten; Harald Burkhardt; Eugen Feist dkk.

Arthritis Research & Therapy, Vol. 20 No. 1 · 2018 · Inggris · DOAJ Scopus

Abstract Background Methotrexate (MTX) remains the anchor drug in rheumatoid arthritis (RA) treatment, but is poorly tolerated or contraindicated in some patients. There is a wealth of data supporting the use of abatacept in combination with MTX, but data on alternative conventional synthetic…

Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis

Axel Finckh; Kim Lauper; Denis Mongin dkk.

BMJ Open, Vol. 11 No. 7 · 2021 · Inggris · DOAJ Scopus

Purpose Rheumatoid arthritis (RA) is an insidious autoimmune disease, with an immunological onset years before diagnosis. Early interventions in preclinical stages could prevent or minimise the progression towards irreversible joint damage. The SCREEN-RA cohort (Evaluation of a SCREENing strategy…

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

Gerd R Burmester; Mark C Genovese; Vibeke Strand dkk.

RMD Open, Vol. 5 No. 2 · 2019 · Inggris · DOAJ Scopus

Objective Evaluate open-label sarilumab monotherapy in patients with rheumatoid arthritis switching from adalimumab monotherapy in MONARCH (NCT02332590); assess long-term safety and efficacy in patients continuing sarilumab during open-label extension (OLE).Methods During the 48-week OLE, patients…

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen; Robert Landewé; J. W. J. Bijlsma dkk.

Annals of the Rheumatic Diseases · 2020 · Inggris · OpenAlex Scopus